Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 12, 2019
- Accepted April 23, 2019
- First Published July 11, 2019.
Author Disclosures
- Christopher G. Tarolli, MD,
- Grace A. Zimmerman, BS,
- Steven Goldenthal, BA,
- Blake Feldman, BA,
- Sarah Berk, MPH,
- Bernadette Siddiqi, MA,
- Catherine M. Kopil, PhD,
- Sohini Chowdhury, MA,
- Kevin M. Biglan, MD, MPH,
- E. Ray Dorsey, MD and
- Jamie L. Adams, MD
- Christopher G. Tarolli, MD,
NONE
NONE
(1) Genzyme - Fellow Scholarship to AAN Annual Meeting (2017) (2) American Academy of Neurology - covered travel cost, AAN Annual Meeting (2018, 2019), Breakthroughs in Neurology Conference (2018), and AAN Fall Conference (2018)
NONE
NONE
NONE
NONE
NONE
NONE
(1) Medtronic - partial salary support for sponsored fellowship in Movement disorders (2017)
NONE
(1) Biosensics
(1) NIH/NINDS
NONE
(1) American Academy of Neurology Institute (2) Michael J. Fox Foundation for Parkinson's Research (3) Greater Rochester Health Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Grace A. Zimmerman, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Steven Goldenthal, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Blake Feldman, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sarah Berk, MPH,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Bernadette Siddiqi, MA,
NONE
NONE
World BI Group (UK), flight and hotel accommodations ExL Events, flight and hotel accommodations
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Catherine M. Kopil, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sohini Chowdhury, MA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kevin M. Biglan, MD, MPH,
NONE
NONE
NONE
Editorial Board, Journal of Huntington disease, 2011- Executive Committee Member, Huntington Study Group 2016-
NONE
NONE
I am currently employed by Eli Lilly Stock/Stock Options, Medical Equipment & Materials: Eli Lilly, 2017, 2018, 2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- E. Ray Dorsey, MD and
Medical Advisory Board, Grand Rounds, an online second opinion service
NONE
received travel funding and/or honoraria from the American Academy of Neurology, American Neurological Association, University of Michigan
Editorial board member for the Journal of Huntington's Disease; Editor of HD Insights; Editor of Digital Biomarkers
NONE
NONE
NONE
23andMe, Abbott, Abbvie, American Well Biogen, Clintrex, DeciBio, Denali Therapeutics, GlaxoSmithKline, Grand Rounds, Karger, Lundbeck, MC10, MedAvante, Medico Legal services, Mednick Associates, NIH/NINDS, Olson Research Group, Optio, Origent Data Sciences, Prilenia, Putnam Associates, Roche, Sanofi, Shire, Sunovion Pharma, Teva, UCB, Voyager Therapeutics,
NONE
NONE
Clinical practice, including telemedicine, as a movement disorder neurologist (20%)
Abbvie, AMC Health, Avid Radiopharmaceuticals, BioMarin, GlaxoSmithKline, Great Lakes Neurotechnologies, Lundbeck, Medtronic, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Teva Pharmaceuticals
National Institute of Neurological Disorders and Stroke, Patient-Centered Outcomes Research Institute
University of California Irvine, Duke University
Burroughs Wellcome Fund, Davis Phinney Foundation, Michael J. Fox Foundation, Safra Foundation, Greater Rochester Health Foundation, Huntington Study Group, National Science Foundation Stock/Stock Options, Medical Equipment & Materials: Grand Rounds (stock options) BlackFynn (stock options)
NONE
NONE
NONE
NONE
NONE
has received compensation for expert testimony
- Jamie L. Adams, MD
NONE
NONE
(1) Huntington Study Group, speaker honorarium
NONE
NONE
NONE
NONE
(1) VisualDx
NONE
NONE
NONE
(1) Biogen (2) Biosensics (3) Pfizer (4) Azevan Pharmaceuticals
NONE
NONE
(1) The Michael J. Fox Foundation (2) Safra Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Neurology (CGT, GAZ, KMB, JLA), University of Rochester Medical Center, NY; Center for Health + Technology (CGT, SG, BF, ERD, JLA), University of Rochester Medical Center, NY; The Michael J. Fox Foundation for Parkinson's Research (SB, BS, CMK, SC), New York; and Early Phase Clinical Development (KMB), Neurosciences, Eli Lilly and Company, Indianapolis, IN.
- Correspondence
Dr. Tarolli christopher_tarolli{at}urmc.rochester.edu
Article usage
The Nerve!: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.